세계의 줄기세포 치료 시장 점유율, 규모, 동향, 산업 분석 리포트 : 유형별, 세포 소스별, 치료 용도별, 지역별, 부문 예측(2022-2030년)

The global stem cell therapy market size is expected to reach USD 900.08 million by 2030 according to a new study by Polaris Market Research. The report "Stem Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Allogeneic, Autologous); By Cell Source; By Therapeutic Application; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing prevalence of chronic disorders, increasing GMP certification approvals for cell therapy production with higher spending in medical research, and the growing number of clinical studies related to stem cell therapies are driving the market.

Increasing collaboration activities by market players are expected to drive the growth of the global market. For instance, in May 2018, Procella Therapeutics and Smartwise collaborated with AstraZeneca Pharmaceuticals to develop stem cell therapies in cardiovascular diseases using Procella Therapeutics' stem cell technology.

COVID-19 has opened up new avenues for stem cell therapy. For COVID-19 patients, several stem cell-based regenerative medicine therapy clinical trials were conducted. Clinical trials are recognized as indispensable components of the pharmaceutical industry and the best hope for patients suffering from diseases.

Stem Cell Therapy Market Report Highlights

The allogenic type accounted for a significant market revenue in 2021 due to the growing demand for omidubicel used to treat cancer patients.

The adipose tissue-derived stem cell will acquire largest market revenue in 2021 as it poses properties such as self-sustainability and multipotential differentiation.

Musculoskeletal disorders segment is anticipated to hold a significant share due to rising R&D expenditures in stem cell therapies to cure these disorders.

North America accounted for the largest market revenue due to advanced healthcare infrastructure and rising R&D units in this region.

The global market is highly competitive owing to large industry players such as Advanced Cell Technology Inc., Angel Biotechnology, Bioheart Inc., Brainstorm Cell Therapeutics, Caladrius Biosciences, Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell, Genea Biocells, Kite Pharma, Lonza, Osiris Therapeutics, PromoCell GmbH, STEMCELL Technologies Inc., Tigenix, and Waisman Biomanufacturing.

Polaris Market Research has segmented the stem cell therapy market report based on type, cell source, therapeutic application, and regions:

Stem Cell Therapy, Type Outlook (Revenue - USD Million, 2018 - 2030)

Allogeneic

Autologous

Stem Cell Therapy, Cell Source Outlook (Revenue - USD Million, 2018 - 2030)

Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)

Bone Marrow-derived MSCs

Placental/Umbilical Cord-derived MSCs

Other Cell Sources

Stem Cell Therapy, Therapeutic Application Outlook (Revenue - USD Million, 2018 - 2030)

Musculoskeletal Disorders

Wounds & Injuries

Cardiovascular Diseases

Surgeries

Inflammatory & Autoimmune Diseases

Neurological Diseases

Other Therapeutic Applications

Stem Cell Therapy, Regional Outlook (Revenue - USD Million, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Stem Cell Therapy Market Insights

• 4.1. Stem Cell Therapy - Industry Snapshot
• 4.2. Stem Cell Therapy Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Ongoing Developments In Regenerative Medicine
    • 4.2.1.2. Rising Funds For Accelerating Stem Cell Research
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Ethical Concern Related To Stem Cell Research
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Stem Cell Therapy Market Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Stem Cell Therapy Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
• 5.3. Allogeneic
  • 5.3.1. Global Stem Cell Therapy Market, by Kinetic, by Allogeneic, 2018 - 2030 (USD Million)
• 5.4. Autologous
  • 5.4.1. Global Stem Cell Therapy Market, by Autologous, by Region, 2018 - 2030 (USD Million)

6. Global Stem Cell Therapy Market, by Cell Source

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
• 6.3. Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
  • 6.3.1. Global Stem Cell Therapy Market, by Adipose Tissue-derived MSCs (Mesenchymal Stem Cells), by Region, 2018 - 2030 (USD Million)
• 6.4. Bone Marrow-derived MSCs
  • 6.4.1. Global Stem Cell Therapy Market, by Bone Marrow-derived MSCs, by Region, 2018 - 2030 (USD Million)
• 6.5. Placental/Umbilical Cord-derived MSCs
  • 6.5.1. Global Stem Cell Therapy Market, by Placental/Umbilical Cord-derived MSCs, by Region, 2018 - 2030 (USD Million)
• 6.6. Other Cell Sources
  • 6.6.1. Global Stem Cell Therapy Market, by Other Cell Sources, by Region, 2018 - 2030 (USD Million)

7. Global Stem Cell Therapy Market, by Therapeutic Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
• 7.3. Musculoskeletal Disorders
  • 7.3.1. Global Stem Cell Therapy Market, by Musculoskeletal Disorders, by Region, 2018 - 2030 (USD Million)
• 7.4. Wounds & Injuries
  • 7.4.1. Global Stem Cell Therapy Market, by Wounds & Injuries, by Region, 2018 - 2030 (USD Million)
• 7.5. Cardiovascular Diseases
  • 7.5.1. Global Stem Cell Therapy Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Million)
• 7.6. Surgeries
  • 7.6.1. Global Stem Cell Therapy Market, by Surgeries, by Region, 2018 - 2030 (USD Million)
• 7.7. Inflammatory & Autoimmune Diseases
  • 7.7.1. Global Stem Cell Therapy Market, by Inflammatory & Autoimmune Diseases, by Region, 2018 - 2030 (USD Million)
• 7.8. Neurological Diseases
  • 7.8.1. Global Stem Cell Therapy Market, by Neurological Diseases, by Region, 2018 - 2030 (USD Million)
• 7.9. Other Therapeutic Applications
  • 7.9.1. Global Stem Cell Therapy Market, by Other Therapeutic Applications, by Region, 2018 - 2030 (USD Million)

8. Global Stem Cell Therapy Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Stem Cell Therapy Market Assessment, By Geography, 2018 - 2030 (USD Million)
• 8.3. Stem Cell Therapy Market - North America
  • 8.3.1. North America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
  • 8.3.2. North America: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 8.3.3. North America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.3.4. Stem Cell Therapy Market - U.S.
    • 8.3.4.1. U.S.: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.3.4.2. U.S.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.3.4.3. U.S.: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.3.5. Stem Cell Therapy Market - Canada
    • 8.3.5.1. Canada: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.3.5.2. Canada.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.3.5.3. Canada: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
• 8.4. Stem Cell Therapy Market - Europe
  • 8.4.1. Europe: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
  • 8.4.2. Europe.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 8.4.3. Europe: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.4. Stem Cell Therapy Market - UK
    • 8.4.4.1. UK: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.4.2. UK.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.4.3. UK: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.5. Stem Cell Therapy Market - France
    • 8.4.5.1. France: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.5.2. France.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.5.3. France: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.6. Stem Cell Therapy Market - Germany
    • 8.4.6.1. Germany: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.6.2. Germany.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.6.3. Germany: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.7. Stem Cell Therapy Market - Italy
    • 8.4.7.1. Italy: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.7.2. Italy.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.7.3. Italy: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.8. Stem Cell Therapy Market - Spain
    • 8.4.8.1. Spain: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.8.2. Spain.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.8.3. Spain: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.9. Stem Cell Therapy Market - Netherlands
    • 8.4.9.1. Netherlands: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.9.2. Netherlands.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.9.3. Netherlands: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.4.10. Stem Cell Therapy Market - Russia
    • 8.4.10.1. Russia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.4.10.2. Russia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.4.10.3. Russia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
• 8.5. Stem Cell Therapy Market - Asia Pacific
  • 8.5.1. Asia Pacific: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
  • 8.5.2. Asia Pacific.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 8.5.3. Asia Pacific: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5.4. Stem Cell Therapy Market - China
    • 8.5.4.1. China: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.4.2. China.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.4.3. China: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5.5. Stem Cell Therapy Market - India
    • 8.5.5.1. India: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.5.2. India.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.5.3. India: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5.6. Stem Cell Therapy Market - Malaysia
    • 8.5.6.1. Malaysia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.6.2. Malaysia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.6.3. Malaysia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5.7. Stem Cell Therapy Market - Japan
    • 8.5.7.1. Japan: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.7.2. Japan.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.7.3. Japan: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5.8. Stem Cell Therapy Market - Indonesia
    • 8.5.8.1. Indonesia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.8.2. Indonesia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.8.3. Indonesia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.5.9. Stem Cell Therapy Market - South Korea
    • 8.5.9.1. South Korea: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.5.9.2. South Korea.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.5.9.3. South Korea: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
• 8.6. Stem Cell Therapy Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
  • 8.6.2. Middle East & Africa.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 8.6.3. Middle East & Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.6.4. Stem Cell Therapy Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.6.4.2. Saudi Arabia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.6.4.3. Saudi Arabia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.6.5. Stem Cell Therapy Market - UAE
    • 8.6.5.1. UAE: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.6.5.2. UAE.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.6.5.3. UAE: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.6.6. Stem Cell Therapy Market - Israel
    • 8.6.6.1. Israel: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.6.6.2. Israel.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.6.6.3. Israel: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.6.7. Stem Cell Therapy Market - South Africa
    • 8.6.7.1. South Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.6.7.2. South Africa.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.6.7.3. South Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
• 8.7. Stem Cell Therapy Market - Latin America
  • 8.7.1. Latin America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
  • 8.7.2. Latin America.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
  • 8.7.3. Latin America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.7.4. Stem Cell Therapy Market - Mexico
    • 8.7.4.1. Mexico: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.7.4.2. Mexico.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.7.4.3. Mexico: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.7.5. Stem Cell Therapy Market - Brazil
    • 8.7.5.1. Brazil: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.7.5.2. Brazil.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.7.5.3. Brazil: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
  • 8.7.6. Stem Cell Therapy Market - Argentina
    • 8.7.6.1. Argentina: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
    • 8.7.6.2. Argentina.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
    • 8.7.6.3. Argentina: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Advanced Cell Technology Inc.
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Angel Biotechnology
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Bioheart Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Brainstorm Cell Therapeutics
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. Caladrius Biosciences
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Celgene Corporation
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Cellartis AB
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. CellGenix GmbH
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Cellular Engineering Technologies Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Gamida Cell
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. Genea Biocells
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Kite Pharma
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development
• 10.13. Lonza
  • 10.13.1. Company Overview
  • 10.13.2. Financial Performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Recent Development
• 10.14. Osiris Therapeutics
  • 10.14.1. Company Overview
  • 10.14.2. Financial Performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Recent Development
• 10.15. PromoCell GmbH
  • 10.15.1. Company Overview
  • 10.15.2. Financial Performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Recent Development
• 10.16. STEMCELL Technologies Inc.
  • 10.16.1. Company Overview
  • 10.16.2. Financial Performance
  • 10.16.3. Product Benchmarking
  • 10.16.4. Recent Development
• 10.17. Tigenix
  • 10.17.1. Company Overview
  • 10.17.2. Financial Performance
  • 10.17.3. Product Benchmarking
  • 10.17.4. Recent Development
• 10.18. Waisman Biomanufacturing
  • 10.18.1. Company Overview
  • 10.18.2. Financial Performance
  • 10.18.3. Product Benchmarking
  • 10.18.4. Recent Development